Literature DB >> 7472496

Regulated secretion of beta-amyloid precursor protein in rat brain.

S A Farber1, R M Nitsch, J G Schulz, R J Wurtman.   

Abstract

The beta-amyloid precursor protein (APP) is a ubiquitous, highly conserved secretory glycoprotein that is expressed at high levels in mammalian brain by neurons, astrocytes, and activated microglia. Secreted APP (APPs) is generated by the cleavage of APP within the beta-amyloid (A beta) portion of its ectodomain. The formation and secretion of APPs can be increased by activation of particular neurotransmitter receptors and subsequent protein phosphorylation. We found that tissue slices from rat cortex, hippocampus, striatum, and cerebellum secrete APPs in vitro. APPs secretion was enhanced by electrical stimulation, but was not associated with a general increase in the release of total protein, lactate dehydrogenase (LDH) activity, or neuronal cell adhesion molecules. The pharmacological profile of stimulation-induced APPs secretion suggests complex interactions between muscarinic receptor subtypes in the tissue slices: in the unstimulated state, activation of Muscarinic M1 receptors increased APPs release while nonspecific activation of multiple muscarinic receptors had little effect on APPs release; in electrically stimulated slices, nonspecific inhibition of muscarinic receptors blunted the increase in APPs secretion. The nonspecific muscarinic agonist carbachol increased APPs secretion only in the presence of an M2 receptor antagonist, suggesting that activation of M2 receptors suppresses APPs formation. These data indicate that secretory APP processing in brain includes depolarization-enhanced cleavage of the cell-associated holoprotein within its ectodomain, and that the net effect of depolorization involves several subtypes of acetylcholine receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7472496      PMCID: PMC6578089     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  31 in total

Review 1.  Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications.

Authors:  Meaghan C Creed; Norton W Milgram
Journal:  Age (Dordr)       Date:  2010-04-20

2.  Deletion of M1 muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo.

Authors:  Albert A Davis; Jason J Fritz; Jürgen Wess; James J Lah; Allan I Levey
Journal:  J Neurosci       Date:  2010-03-24       Impact factor: 6.167

Review 3.  Protease pathways in peptide neurotransmission and neurodegenerative diseases.

Authors:  Vivian Y H Hook
Journal:  Cell Mol Neurobiol       Date:  2006-05-25       Impact factor: 5.046

4.  GRK5 deficiency accelerates {beta}-amyloid accumulation in Tg2576 mice via impaired cholinergic activity.

Authors:  Shaowu Cheng; Longxuan Li; Shuangteng He; Jun Liu; Yuning Sun; Minchao He; Kenneth Grasing; Richard T Premont; William Z Suo
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

5.  Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice.

Authors:  H Meziane; J C Dodart; C Mathis; S Little; J Clemens; S M Paul; A Ungerer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

Review 6.  Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease.

Authors:  A I Levey
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

7.  Turnover of amyloid beta-protein in mouse brain and acute reduction of its level by phorbol ester.

Authors:  M J Savage; S P Trusko; D S Howland; L R Pinsker; S Mistretta; A G Reaume; B D Greenberg; R Siman; R W Scott
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

8.  Vasopressin and bradykinin regulate secretory processing of the amyloid protein precursor of Alzheimer's disease.

Authors:  R M Nitsch; C Kim; J H Growdon
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

9.  DEEP BRAIN STIMULATION IN MIDLINE THALAMIC REGION FACILITATES SYNAPTIC TRANSMISSION AND SHORTTERM MEMORY IN A MOUSE MODEL OF ALZHEIMER'S DISEASE.

Authors:  Isabel Arrieta-Cruz; Constantine Pavlides; Giulio Maria Pasinetti
Journal:  Transl Neurosci       Date:  2010-09       Impact factor: 1.757

10.  A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning.

Authors:  Jana K Shirey; Ashley E Brady; Paulianda J Jones; Albert A Davis; Thomas M Bridges; J Phillip Kennedy; Satyawan B Jadhav; Usha N Menon; Zixiu Xiang; Mona L Watson; Edward P Christian; James J Doherty; Michael C Quirk; Dean H Snyder; James J Lah; Allan I Levey; Michelle M Nicolle; Craig W Lindsley; P Jeffrey Conn
Journal:  J Neurosci       Date:  2009-11-11       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.